Menu
Intsel Chimos laboratory holds several Marketing Authorizations (‘MA’) across various therapeutic areas from niche products to higher volumes in order to provide a comprehensive offer to hospitals and pharmacies.
We place great importance on the choice of the medicines we market in order to guarantee the quality of our services and thus benefit the patients.
We are the owner and exploitant of Alprostadil Intsel Chimos®, which is a prostaglandin analogue.
We are the exploitant of Cufence®, which is a drug for the digestive system and metabolism.
We are the exploitant of Farydak®, an antineoplastic drug used in cancer treatment.